Myriad Genetics, Inc.’s recent filing unveils that its President and CEO DIAZ PAUL J unloaded Company’s shares for reported $1.88 million on May 15 ’24. In the deal valued at $25.07 per share,75,000 shares were sold. As a result of this transaction, DIAZ PAUL J now holds 1,066,166 shares worth roughly $24.69 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, DIAZ PAUL J sold 95,000 shares, generating $2,394,798 in total proceeds. Upon selling the shares at $25.21, the President and CEO now owns 1,141,166 shares.
Before that, DIAZ PAUL J sold 57,844 shares. Myriad Genetics, Inc. shares valued at $1,453,550 were divested by the President and CEO at a price of $25.13 per share. As a result of the transaction, DIAZ PAUL J now holds 1,236,166 shares, worth roughly $28.63 million.
Leerink Partners upgraded its Myriad Genetics, Inc. [MYGN] rating to an Outperform from a a Market perform in a research note published on May 08, 2024; the price target was increased to $35 from $25. Wells Fargo began covering MYGN with “an Equal weight” recommendation on December 19, 2023. Guggenheim started covering the stock on December 14, 2023. It rated MYGN as “a Buy”.
Price Performance Review of MYGN
On Friday, Myriad Genetics, Inc. [NASDAQ:MYGN] saw its stock fall -0.47% to $23.16. Over the last five days, the stock has lost -8.42%. Myriad Genetics, Inc. shares have risen nearly 21.00% since the year began. Nevertheless, the stocks have risen 0.96% over the past one year. While a 52-week high of $25.95 was reached on 05/10/24, a 52-week low of $13.82 was recorded on 01/08/24. SMA at 50 days reached $21.27, while 200 days put it at $19.31. A total of 0.37 million shares were traded, compared to the trading of 0.58 million shares in the previous session.
Levels Of Support And Resistance For MYGN Stock
The 24-hour chart illustrates a support level at 22.91, which if violated will result in even more drops to 22.66. On the upside, there is a resistance level at 23.46. A further resistance level may holdings at 23.76. The Relative Strength Index (RSI) on the 14-day chart is 53.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.75, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 43.26%. Stochastics %K at 61.82% indicates the stock is a holding.
The most recent change occurred on December 13, 2023 when Wolfe Research began covering the stock and recommended ‘”an Outperform”‘ rating along with a $28 price target.
